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Aim: To evaluate retrospectively the cases of syphilis who applied to different clinics of our hospital 
in the last 5 years and to emphasize the importance of admission screening tests in the diagnosis of 
neurosyphilis which is a rare but serious form of syphilis. 
Methods: Sixty-one patients who admitted to different clinics of our hospital between 2013 and 2017 
with different clinical manifestations and positive Venereal Disease Research Laboratory (VDRL) 
and Treponema pallidum microhemagglutination assay (TPHA) tests were recorded and analyzed 
retrospectively.  
Results: Both VDRL and TPHA tests were positive in 44 males with a mean age of 57.4 ± 18.4 years 
and 17 females with a mean age of 65.3 ± 19.1 years. It was found that of the 61 patients who were 
examined for differential diagnosis of syphilis, 36 (%59) of them were referred from neurology clinic, 
15 (25%) from infectious diseases clinic, 7 (12%) from dermatology clinic and 3 (4%) from 
gynecology clinic.   The clinical presentation was venereal chancre in 15 cases, asymptomatic 
ischemic brain lesions in 17 cases, acute ischemic stroke in 13 cases, movement disorder in three 
cases, tabes dorsalis in two cases, tendinitis-arthritis in eight cases, Amyotrophic lateral sclerosis 
(ALS) in one case, Deep venous thrombosis (DVT) in one case, and pulmonary nodule in one case.   
Conclusions: In conclusion, syphilis is often overlooked in the differential diagnosis in patient with 
neurological findings. Since neurosyphilis is an easily treatable disease, it should be considered in the 
differential diagnosis of patients presenting with neurological findings. 
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Introduction 
Syphilis caused by Treponema pallidum is a 
sexually transmitted multisystemic disease that 
can be treated with early diagnosis [1, 2]. The 
widespread use of penicillin and other 
antibiotics has led to a decrease in the number of 
syphilis cases [3]. However, it remains 
important as one of the sexually transmitted 
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diseases in developing countries. On the other 
hand, the incidence of the disease increases with 
AIDS and HIV seropositivity [4].  
Since the clinical symptomatology of the disease 
covers a wide spectrum and mimics many 
diseases, it is defined as “the great imitator" [5] 
Neurosyphilis develops in about 5% of cases 
infected with Treponema pallidum [6]. Central 
nervous system involvement of syphilis may 
occur early or late stage of the infection. 
Meningitis, vision and hearing loss, and stroke 
are common in early neurosyphilis. Cognitive 
involvement, hearing loss and gait disturbances 
are seen more frequently in the late period 
neurosyphilis [7].  
The most common serological tests used for 
screening the infection are nontreponemal and 
treponemal tests. Nontreponemal tests such as 
Venereal Disease Research Laboratory (VDRL) 
or Rapid Plasma Reagin (RPR) show host 
immunoglobulin M (IgM) and IgG antibodies 
against lipoidal material released from damaged 
host cells and cardiolipin released from 
treponemas [8]. Nontreponemal tests are used 
qualitatively for screening in the diagnosis of 
infection or quantitatively in the follow-up of 
the treatment [9, 10]. Nontreponemal tests are 
easily accessible, inexpensive and easily 
applicable to the study of multiple samples [8]. 
The standard treponemal tests used today are the 
Microhemagglutination Assay (MHA-TP) or 
the Treponema pallidum 
microhemagglutination assay (TPHA) and the 
Flourescent Treponemal Antibody-Absorption 
(FTA-ABS) and 'FTAABS double staining' tests 
and are generally used to confirm positive 
results for nontreponemal tests [11, 12]. 
The aim of the present study was to evaluate 
retrospectively the cases of syphilis who applied 
to different clinics of our hospital in the last 5 
years and to emphasize the importance of 
admission screening tests in the diagnosis of 




After approval of the local ethics committee, the 
data of 61 patients who admitted to different 
clinics of Bolu Abant Izzet Baysal University 
Education and Research Hospital between 2013 
and 2017 with different clinical manifestations 
and positive VDRL and TPHA tests were 
recorded and analyzed retrospectively. All 
patients underwent lumber puncture to rule out 
neurosyphilis. The diagnosis of neurosyphilis 
was based on clinical, laboratory and CSF 
findings. Age, gender and laboratory data of the 
patients were recorded. All patients were 
informed about the study and a written informed 
consent was obtained from each patient. All of 
the enrolled patients were HIV negative. The 
study was conducted in accordance with the 
Declaration of Helsinki. For all statistical 
analysis, statistical software package 18.0 for 
Windows (SPSS Inc., Chicago, IL, USA) was 
used. Descriptive statistics and frequency 
analysis were used. Data are presented as mean 
± standard deviation for quantitative data, 
number (n) and percent (%) for categorical data. 
 
Results  
Both VDRL and TPHA tests were positive in 44 
males with a mean age of 57.4 ± 18.4 years and 
17 females with a mean age of 65.3 ± 19.1 years. 
It was found that of the 61 patients who were 
examined for differential diagnosis of syphilis, 
36 (%59) of them were referred from neurology 
clinic, 15 (25%) from infectious diseases clinic, 
7 (12%) from dermatology clinic and 3 (4%) 
from gynecology clinic.   Of the 13 patients who 
underwent ear nose throat (ENT) and 
audiometric examination, three of them were 
normal and 10 patients had sensorineural 
hearing loss, and 48 patients had no audiometric 
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examination. The clinical presentation was 
venereal chancre in 15 cases, asymptomatic 
ischemic brain lesions in 17 cases, acute 
ischemic stroke in 13 cases, movement disorder 
in three cases, tabes dorsalis in two cases, 
tendinitis-arthritis in eight cases, Amyotrophic 
lateral sclerosis (ALS) in one case, Deep venous 
thrombosis (DVT) in one case, and pulmonary 
nodule in one case.  All patients were found to 























In our study, in the last 5 years 31% of the cases 
diagnosed with syphilis in our hospital were 
diagnosed by infectious diseases, dermatology 
and gynecology clinic and the most common 
complaint was venereal chancre. Fifty-nine 
percent of the patients were diagnosed with 
syphilis by the referral of neurology and these 
patients were evaluated as late stage 
neurosyphilis. The most common clinical signs 
of neurosyphilis are dementia, stroke, tabes 
dorsalis, vasculitis, and parkinsonism [13]. In 
the present study, the most common clinical 
presentation was acute ischemic stroke in 
patients diagnosed with neurosyphilis. 
Syphilis caused by Treponema pallidum is an 
infectious disease that is widely reported all over 
the world [14]. The organism can invade the 
central nervous system in the early period. The 
disease spreads by "neuroinvasion" during the 























involvement is one of the most important 
manifestations of syphilis. Typically, 
neurosyphilis is defined as a late finding, but 
neuroinvasion and neurological disease are seen 
in both early and late syphilis, and Treponema 
pallidum is often detected in cerebrospinal fluid 
(CSF) in early stage syphilis patients [15, 16]. 
Neurosyphilis is most commonly asymptomatic, 
other forms of neurosyphilis include   
meningeal, meningovascular and parenchymal 
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involvement including general paresis and tabes 
dorsalis [17]. Asymptomatic neurosyphilis 
poses a risk of developing subsequent 
neurological symptoms in the partially treated 
patients. In asymptomatic neurosyphilis, 
treatment can be significantly delayed. Early 
neurosyphilis was common in this cohort. It has 
been shown that highly active antiretroviral 
therapy to reverse immunosuppression may 
alleviate neurological complications of syphilis 
[18, 19]. With the widespread use of antibiotics, 
atypical forms in which symptoms are 
intertwined instead of classical neurosyphilis 
forms have started to be seen more frequently, 
which makes diagnosis difficult [20]. In a 
multivariate regression analysis, headache was a 
protective factor in NS patients, whereas double 
vision was significantly associated with poor 
outcomes. They concluded that double opinion 
gave negative results for NS patients. In 
addition, they suggested that a high clinical 
suspicion is needed for the diagnosis of NS, and 
that the presence of headache in syphilitic 
patients may help in the early diagnosis of 
central nervous system disease [21]. 
In recent years, there have been studies on 
neurological involvement in HIV-negative 
syphilis patients in addition to HIV-positive 
patients [22, 23]. All patients with the 
neurological findings in the current study were 
found to be HIV negative.  
In this study, we aimed to draw attention to 
neurosyphilis in the differential diagnosis of the 
patients with ischemic cerebrovascular disease, 
parkinsonism, dementia and neuropsychiatric 
findings. Syphilis is often overlooked in the 
differential diagnosis in these patient groups 
which are very common in daily clinical 
practice. Therefore, many patients may be 
deprived of the treatment. It also should be kept 
in mind that syphilis positive patients should be 
asked about their partners and if necessary, the 
partners may be treated. 
 
Conclusion 
In conclusion, neurosyphilis, an easily treatable 
disease, should be considered in the differential 
diagnosis of patients presenting with such 
neurological findings. 
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